Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 8 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
PHARMACIE NIMAX from Grez-Doiceau, company number BE0882213317, closed financial year 2024 with a result of € 30,357 after tax. For that financial year PHARMACIE NIMAX recorded a gross margin of € 113,086 and equity of € -399,811. Compared with financial year 2023, the result moved from € -795,668 to € 30,357. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.
€ -399,811
▲ € 30,357 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 30,357
▲ still € 795,668 loss in 2023
Profit after tax over the fiscal year.
€ 22,404
▼ 52% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € -557,035.
People and assets in 2024
€ 4,278
▼ 25% vs 2023
Of which on lease € 918.
Debts at end 2024
€ 145,831
▲ 66% vs 2023
€ 48,885 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 35,505
▲ 24% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 10,025
▼ 53% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Revenue | - | € 24,000 | - | - | |
| Gross margin | - | - | € 86,717 | € 113,086 | ▲ 30% |
| Profit after taxes | € -25,748 | € 14,361 | € -795,668 | € 30,357 | ▲ € 826,025 |
| Equity | € 351,139 | € 365,500 | € -430,168 | € -399,811 | ▲ € 30,357 |
| Total debts | € 1,139,122 | € 1,127,604 | € 970,927 | € 1,324,215 | ▲ 36% |
| Cash | € 3,665 | € 6,912 | € 46,921 | € 22,404 | ▼ 52% |
| Land & buildings | € 323,538 | € 313,271 | € 368,713 | € 645,482 | ▲ 75% |
| Retained profit | € 193,915 | € 208,276 | € -587,392 | € -557,035 | ▲ € 30,357 |
| Bank debt | € 153,448 | € 120,861 | € 87,782 | € 145,831 | ▲ 66% |
| Balance sheet total | € 1,515,261 | € 1,518,104 | € 565,759 | € 949,404 | ▲ 68% |
Key figures of PHARMACIE NIMAX, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMACIE NIMAX?
What happened at PHARMACIE NIMAX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 30,357. filed late Source: NBB ↗
- New establishment in Grez-Doiceau. KBO
- Start of the company according to the CBE. KBO
In short
From € 25,748 loss in 2021 to € 30,357 profit in 2024.
Paid € 33,988 in corporate taxes since 2021.
Best year ever: 2024, with € 30,357 profit.
A new publication or filing at PHARMACIE NIMAX? We notify you, reason included.
Follow PHARMACIE NIMAXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE NIMAX are Carine Grzybowski and Claude Nimax.
Directors
According to the 2024 annual accounts
Carine Grzybowski
Director
Claude Nimax
Director
Establishments
Establishment units
Physical locations of this company
Rue de Hamme-Mille 28
1390 Grez-Doiceau
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0882.213.317
- VAT number
- BE 0882.213.317
- Registered office
- Rue de Hamme-Mille 28, 1390 Grez-Doiceau
- Names & denominations
- PHARMACIE NIMAX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 June 2006
- Peppol
- Active · Active since 25 Nov 2025
- Activities · NACE
Diverse ondersteunende activiteiten ten behoeve van voorzieningen
Beheer van overig onroerend goed
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.